Literature DB >> 12100972

Cholecalciferol treatment restores the relaxant responses of spontaneously hypertensive rat arteries to bradykinin.

Antonio C.R. Borges1, Teresa Feres, Lucia M. Vianna, Therezinha B. Paiva.   

Abstract

The vasodilation and hyperpolarization induced by bradykinin (BK) in the mesenteric vascular bed and mesenteric arteries from spontaneously hypertensive rats (SHR) and from normotensive Wistar rats (NWR), as well as Wistar Kyoto rats (WKY), was investigated before and after prolonged oral treatment with cholecalciferol (125 mg kg(-1) body weight per day) for 3 weeks. The cholecalciferol treatment caused a decrease in the SHR blood pressure, as well as a normalization in the resting potential of the smooth muscle cell membrane of mesenteric arteries and restored their hyperpolarizing response to BK. The concentration-response curves for the vasodilator effect of BK on the mesenteric vascular bed were significantly decreased in SHR and in WKY when compared with NWR. Cholecalciferol treatment improved the maximum responses of the SHR preparation, bringing them to levels similar to those of the NWR preparations, which themselves were unaffected by the treatment. In the presence of apamin, a Ca(2+)-dependent K(+) channel inhibitor, the maximum responses to BK in preparations from NWR or cholecalciferol-treated SHR decreased to values similar to those observed in untreated SHR. Our results indicate that the low responsivity of the SHR resistance vessels to the relaxant effect of BK is due to impaired Ca(2+)-dependent K(+) channels and that reversion of this impairment contributes to the blood pressure reduction caused by the cholecalciferol treatment. However, the mechanism of the low responsivity in WKY remains to be investigated.

Entities:  

Year:  2002        PMID: 12100972     DOI: 10.1016/s0928-4680(02)00036-6

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  3 in total

1.  Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.

Authors:  Karen L Margolis; Roberta M Ray; Linda Van Horn; Joann E Manson; Matthew A Allison; Henry R Black; Shirley A A Beresford; Stephanie A Connelly; J David Curb; Richard H Grimm; Theodore A Kotchen; Lewis H Kuller; Sylvia Wassertheil-Smoller; Cynthia A Thomson; James C Torner
Journal:  Hypertension       Date:  2008-09-29       Impact factor: 10.190

Review 2.  Potential for vitamin D receptor agonists in the treatment of cardiovascular disease.

Authors:  J R Wu-Wong
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 3.  Vitamin D and Cardiovascular Risk: which Implications in Children?

Authors:  Silvia Savastio; Erica Pozzi; Francesco Tagliaferri; Roberta Degrandi; Roberta Cinquatti; Ivana Rabbone; Gianni Bona
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.